IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Cancer Treatment and Research Communications

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

2.49

h-Index

2023-2024

 23

Rank

2023-2024

 6300

SJR

2023-2024

 0.793

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Cancer Treatment and Research Communications
Abbreviation Cancer Treat. Res. Commun.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q2); Cancer Research (Q3)
h-index 23
Overall Rank/Ranking 6300
SCImago Journal Rank (SJR) 0.793
Impact Score 2.49
Publisher Elsevier Ltd
Country United Kingdom
ISSN 24682942
Best Quartile Q2
Coverage History 2016-2023




About Cancer Treatment and Research Communications


Cancer Treatment and Research Communications is a journal covering the technologies/fields/categories related to Oncology (Q2); Cancer Research (Q3). It is published by Elsevier Ltd. The overall rank of Cancer Treatment and Research Communications is 6300. According to SCImago Journal Rank (SJR), this journal is ranked 0.793. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 23. The best quartile for this journal is Q2.

The ISSN of Cancer Treatment and Research Communications journal is 24682942. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Treatment and Research Communications is cited by a total of 1166 articles during the last 3 years (Preceding 2023).


Cancer Treatment and Research Communications Impact IF 2023-2024


The Impact IF 2023 of Cancer Treatment and Research Communications is 2.49, which is computed in 2024 as per its definition. Cancer Treatment and Research Communications IF is decreased by a factor of 0.03 and approximate percentage change is -1.19% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Cancer Treatment and Research Communications Impact IF 2024 Prediction


Impact IF 2023 of Cancer Treatment and Research Communications is 2.49. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Cancer Treatment and Research Communications. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 2.49
2022 2.52
2021 2.00
2020 1.56
2019 0.53
2018 0.60
2017 0.43
2016 0.37
2015 0.31
2014 0.20

Cancer Treatment and Research Communications h-index


  Table Setting

Cancer Treatment and Research Communications has an h-index of 23. It means 23 articles of this journal have more than 23 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Cancer Treatment and Research Communications ISSN


The ISSN of Cancer Treatment and Research Communications is 24682942. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Cancer Treatment and Research Communications Rank and SCImago Journal Rank (SJR)


The overall rank of Cancer Treatment and Research Communications is 6300. According to SCImago Journal Rank (SJR), this journal is ranked 0.793. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Cancer Treatment and Research Communications by Year


Year SJR
2023/2024 Coming Soon
2023 0.793
2022 0.674
2021 0.520
2020 0.459
2019 0.256
2018 0.297
2017 0.250
2016 0.182
2015 0.113
2014 0.146

Ranking of Cancer Treatment and Research Communications by Year


Year Ranking
2023/2024 Coming Soon
2023 6300
2022 7460
2021 9620
2020 10819
2019 15944
2018 13810
2017 15037
2016 18877
2015 25944
2014 20972

Cancer Treatment and Research Communications Publisher


Table Setting

Cancer Treatment and Research Communications is published by Elsevier Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2016-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Cancer Treatment and Research Communications is Cancer Treat. Res. Commun.. This abbreviation ('Cancer Treat. Res. Commun.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Cancer Treatment and Research Communications


If your research field is/are related to Oncology (Q2); Cancer Research (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Cancer Treatment and Research Communications?

Cancer Treatment and Research Communications latest impact IF is 2.49. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 2.52 (2022) and 0.20 (2014), respectively, in the last 10 years. Moreover, its average IS is 1.1 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Cancer Treatment and Research Communications?

The Cancer Treatment and Research Communications has an SJR (SCImago Journal Rank) of 0.793, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.793 in 2023 and the lowest being 0.113 in 2015. Furthermore, the average SJR of the Cancer Treatment and Research Communications over the previous 10-year period stands at 1.1.


What's the latest h-index of the Cancer Treatment and Research Communications?

The latest h-index of the Cancer Treatment and Research Communications is 23.


Who's the publisher of the Cancer Treatment and Research Communications?

The Cancer Treatment and Research Communications is published by the Elsevier Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Cancer Treatment and Research Communications?

The Cancer Treatment and Research Communications is currently ranked 6300 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 6300 in 2023 and its lowest position of 25944 in 2015.


What's the abbreviation or short name for the Cancer Treatment and Research Communications?

The standard ISO4 abbreviation for the Cancer Treatment and Research Communications is Cancer Treat. Res. Commun..


Is the "Cancer Treatment and Research Communications" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Cancer Treatment and Research Communications is classified as a journal that the Elsevier Ltd publishes.


What's the scope or major areas of the Cancer Treatment and Research Communications?

The Cancer Treatment and Research Communications encompasses the following areas:

  • Oncology
  • Cancer Research

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Cancer Treatment and Research Communications?

The Cancer Treatment and Research Communications is assigned the following International Standard Serial Numbers (ISSN): 24682942.


What's the best quartile of the Cancer Treatment and Research Communications?

The best quartile for the Cancer Treatment and Research Communications is Q2 (2023).


What's the coverage history of the Cancer Treatment and Research Communications?

The Cancer Treatment and Research Communications coverage history can be summarized as follows: 2016-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Discourse journal 6196 Routledge 65 2.36
British Journal of Special Education journal 16076 Wiley-Blackwell Publishing Ltd 44 0.78
Libyan Studies journal 19526 Cambridge University Press 9 0.30
Acta Periodica Technologica journal 23723 University of Novi Sad, Faculty of Technology 21 0.31
Consulting engineer Barrington journal 24079 Cahners Pub. Co. 0 0.00
Clinical Interventions in Aging journal 5314 Dove Medical Press Ltd. 104 3.55
Journal of Evolutionary Psychology journal 28897 Akademiai Kiado 0 0.00
Himalayan Geology journal 15365 Wadia Institute of Himalayan Geology 19 1.00
Perspectives in health information management / AHIMA, American Health Information Management Association journal 13267 American Health Information Management Association 31 1.32
Journal of Tropical Agriculture journal 22223 Kerala Agricultural University 19 0.25

Check complete list




Year wise Impact Score (IS) of Cancer Treatment and Research Communications

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 2.49
2022 2.52
2021 2.00
2020 1.56
2019 0.53
2018 0.60
2017 0.43
2016 0.37
2015 0.31
2014 0.20



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Journal of Thoracic Oncology
Elsevier Inc. | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All